RxDoctor Payments Data

Richard Bennett, MD

Psychiatry · Orchard Park, NYNPI 1821053026

Payments from drug & device makers

$14,255in general payments, 2019–2025

Across 792 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Alkermes, Inc.$1K
  • Neurocrine Biosciences, Inc.$1K
  • Lundbeck LLC$1K
  • plus $5K from 23 others

What the payments were for

  • Food & beverage$14,09499%
  • Education$1621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,255 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$52,042
Medicare patients
149
Services billed
886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl69$112,636
TrintellixVortioxetine Hydrobromide54$37,823
RexultiBrexpiprazole20$35,018
AuvelityDextromethorphan Hbr/Bupropion28$26,414
LexaproEscitalopram Oxalate26$17,565
AbilifyAripiprazole14$15,083
Desvenlafaxine Succinate ErDesvenlafaxine Succinate304$14,384
Duloxetine Hcl362$10,498
DayvigoLemborexant23$9,515
Bupropion XlBupropion Hcl341$8,128
Adderall XrDextroamphetamine/Amphetamine11$6,460
Venlafaxine Hcl ErVenlafaxine Hcl287$6,229
Clonazepam649$6,081
Buspirone Hcl304$6,072
Trazodone Hcl361$5,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Lexapro$3,512$130,20095 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$797$37,82354 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,399$35,01820 claims
Axsome Therapeutics, Inc.Auvelity$493$26,41428 claims
E.r. Squibb & Sons, L.L.C.Abilify$41$15,08314 claims
Eisai Inc.Dayvigo$92$9,51523 claims
Almatica Pharma LLCSertraline Hcl$114$2,044179 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Orchard Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →